Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Intrathecal Lumbar Administration of AAV9/CLN7 for Treatment of CLN7 Disease

NCT04737460 is registered in ClinicalTrials.gov with Benjamin Greenberg as lead sponsor.

NCT NCT04737460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04737460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Intrathecal Lumbar Administration of AAV9/CLN7 for Treatment of CLN7 Disease
Lead sponsor
Benjamin Greenberg
Phase
Phase 1
Overall status
Active, not recruiting
Start date
May 4, 2021
Completion date
February 1, 2029
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cln7